Clinical Trials Browser

Not yet recruiting × Recurrence × Temozolomide × Clear all

NCT06639607 2026-03-10

PRiME II

Phase 1/2 Not yet recruiting

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

NCT07444918 2026-03-03

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Phase 2 Not yet recruiting

Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma